Rag1-KO(Rag1-EGFP)

Nomenclature

B6;129S-Rag1tm1(loxP-EGFP-PolyA-loxP-Neo-loxP)Smoc

Cat. NO.

NM-KI-00069

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Rag1

Model Description

A loxP-EGFP-PolyA-loxP-Neo-loxP expression cassette was knocked into the Rag1 gene start codon site. As a Rag1 knockout mouse model, this stain can be used in subcutaneous inoculation of liver cancer tissues and tumor cells. Tumors can esaily form and grow. The amount of T and B lymphocytes in peripheral blood of mice was extremely low tested by FACS, which was comparable to or lower than that of Nude mice, and there was a significant difference compared with wild type mice. The pathological sections of HE staining of tumor tissues showed that the tumor sections of Rag1 KO mice and Nude mice were similar. This strain has the potential to replace Nude, NOD-SCID mice as a tumor-bearing mouse model.
Research Application:Immunodeficiency,tumor-bearing model

Validation Data

rag1.jpg

Fig.1 Construction strategy of Rag1-KO.

rag1-rag2-外周血.png

Fig.2 Loss of T and B cells in peripheral blood of Rag1-KO and Rag2-KO mice.

rag1-rag2-脾脏.png

Fig.3 Loss of T and B cells in Spleen of Rag1-KO and Rag2-KO mice.

rag1-rag2-胸腺.png

Fig.4 Loss of T and B cells in thymus of Rag1-KO and Rag2-KO mice.

image.png

Fig.5 Detection of EGFP expression in CD45+ cells in spleen, blood, thymus, and bone marrow of 8.7-week-old female WT and HO Rag1-KO(Rag1-EGFP) mice.

image.png

Fig.6 Detection of mouse IgG(A) and IgM(B) expression in serum by ELISA. (male, 5~6wks, n=3)

Abbr. HO, homozygous; WT, wild type; N.D. not detected.

Rag1-Rag2.png

Fig.7 Tumorigenicity results following inoculation with A549 tumor cells in Balb/c nude, NOD-Scid, Rag1-KO and Rag2-KO mice.


Table1. Complete blood count of Rag1-KO (Rag1-EGFP) mice

image.png

Table 2. Serum biochemical analysis of Rag1-KO (Rag1-EGFP) mice.

image.png




You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more